Trial Profile
The Role of Hemolysis in Promoting Thrombosis During Mechanical Circulatory Support With Continuous Flow Pumps (Aim 2)
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms SToPClot
- 06 Nov 2019 Planned number of patients changed from 44 to 46.
- 06 Nov 2019 Planned End Date changed from 30 Aug 2022 to 30 Aug 2023.
- 06 Nov 2019 Planned primary completion date changed from 30 Jun 2022 to 30 Aug 2023.